English 日本語

#PharmaceuticalDevelopment

List of IR information related to "PharmaceuticalDevelopment".

1 IR Posts
1 Companies
11 days ago Last Updated

Filters

Reset
Period:
Importance:
1 IR Posts
4519 Chugai Pharmaceutical Co., Ltd.
2026/03/23
Notice Regarding Discontinuation of Development of GYM329 (emugrobart) for Spinal Muscular Atrophy and Facioscapulohumeral Muscular Dystrophy

Chugai Pharmaceutical announced that Roche will discontinue clinical development of the anti-myostatin antibody emugrobart for spinal muscular atrophy and facioscapulohumeral muscular dystrophy. Development targeting obesity will continue.

#ChugaiPharmaceuticalCoLtd #DrugDevelopmentDiscontinuation #PharmaceuticalDevelopment
Scroll to Top